Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10) deficiency
Top Cited Papers
- 5 August 2014
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 38 (1), 145-156
- https://doi.org/10.1007/s10545-014-9749-9
Abstract
Coenzyme Q10 is a remarkable lipid involved in many cellular processes such as energy production through the mitochondrial respiratory chain (RC), beta-oxidation of fatty acids, and pyrimidine biosynthesis, but it is also one of the main cellular antioxidants. Its biosynthesis is still incompletely characterized and requires at least 15 genes. Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ10 deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease. The pathogenesis is complex and related to the different functions of CoQ10. It involves defective ATP production and oxidative stress, but also an impairment of pyrimidine biosynthesis and increased apoptosis. CoQ10 deficiency can also be observed in patients with defects unrelated to CoQ10 biosynthesis, such as RC defects, multiple acyl-CoA dehydrogenase deficiency, and ataxia and oculomotor apraxia. Patients with both primary and secondary deficiencies benefit from high-dose oral supplementation with CoQ10. In primary forms treatment can stop the progression of both SRNS and encephalopathy, hence the critical importance of a prompt diagnosis. Treatment may be beneficial also for secondary forms, although with less striking results. In this review we will focus on CoQ10 biosynthesis in humans, on the genetic defects and the specific clinical phenotypes associated with CoQ10 deficiency, and on the diagnostic strategies for these conditions.Keywords
This publication has 88 references indexed in Scilit:
- Heterogeneity of Coenzyme Q10DeficiencyArchives of Neurology, 2012
- Renal involvement in mitochondrial cytopathiesPediatric Nephrology, 2011
- Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant miceEMBO Molecular Medicine, 2011
- Expression of the human atypical kinase ADCK3 rescues coenzyme Q biosynthesis and phosphorylation of Coq polypeptides in yeast coq8 mutantsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011
- Involvement of Mitochondrial Ferredoxin and Para-Aminobenzoic Acid in Yeast Coenzyme Q BiosynthesisCell Chemical Biology, 2010
- A Nonsense Mutation in COQ9 Causes Autosomal-Recessive Neonatal-Onset Primary Coenzyme Q10 Deficiency: A Potentially Treatable Form of Mitochondrial DiseaseAmerican Journal of Human Genetics, 2009
- The yeast Coq4 polypeptide organizes a mitochondrial protein complex essential for coenzyme Q biosynthesisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- RETRACTED: Activation of the PPAR/PGC-1α Pathway Prevents a Bioenergetic Deficit and Effectively Improves a Mitochondrial Myopathy PhenotypeCell Metabolism, 2008
- ADCK3, an Ancestral Kinase, Is Mutated in a Form of Recessive Ataxia Associated with Coenzyme Q10 DeficiencyAmerican Journal of Human Genetics, 2008
- CABC1 Gene Mutations Cause Ubiquinone Deficiency with Cerebellar Ataxia and SeizuresAmerican Journal of Human Genetics, 2008